Abstract
Cardiomyopathies are a varied group of heart diseases that are characterized by abnormalities of the heart muscle. Although these generally exclude those secondary to coronary artery disease, hypertension, congenital, valvular, or pericardial pathology, this definition has loosened, and terms such as “ischemic cardiomyopathy” or “hypertensive cardiomyopathy” have become popular (Fig. 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Devereux RB. Is the electrocardiogram still useful for detection of left ventricular hypertrophy? Circulation 1990;81:1144–1146.
Faber L, Ziemssen P, Seggewiss H. Targeting percutaneous translu-minal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. I Am Soc Echocardiogr 2000;13:1074–1079.
Falk RH, Plenn JF, Deering T, et al. Sensitivity and specificity of echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987;59:418–422.
Ho HH, Lee KL, Lau CP, Ts, HF. Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. Am J Med 2004;116:19–23.
Klein AL, Hatle LK, Burstow DJ, et al. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990;15:99–108.
Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992;85:1651–1660.
Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997;336:267–276.
Leenen FH. Increased risk attributed to left ventricular hypertrophy in hypertension. Curr Opin Cardiol 1996;11:464–470.
Liebson PR, Grandits G, Prineas R, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993;87:476–486.
Mason JW. Classification of cardiomyopathies. In: Fuster V, Wayne Alexander R, O’Rourke RA, eds. Hurst’s The Heart Manual of Cardiology, 11th ed. New York: McGraw-Hill, 2004: 1883–1888.
Mathew V, Olson LJ, Gertz MA, Hayes DL. Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol 1997;80:1491, 1492.
Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling MFVP in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. J Am Coll Cardiol 1993;22:808–815.
Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5–10.
Pollick C, Rakowski H, Wigle ED. Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation 1984;69:43–49.
Reisinger J, Dubrey SW, Lavalley M, Skinner M, Falk RH. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol 1997;30:1046–1051.
Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of the cardiomyopathies. Circulation 1996;93:841, 842.
Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 1994;90:2772–2779.
Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111:472–479.
Simons M, Isner JM. Assessment of relative sensitivities of nonin-vasive tests for cardiac amyloidosis in documented cardiac amyloidosis. Am J Cardiol 1992;69:425–427.
Siqueira-Filho AG, Cunha CLP, Tajik AJ, et al. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 1981;63:188–196.
Stevenson LW. Diseases of the myocardium. In: Goldman L, Ausiello D, eds. Textbook of Medicine, 22nd ed. Philadelphia: Saunders, 2004:441–454.
Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol 2001;38:11–18.
Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539–548.
Wynne J, Braunwald E. The cardiomyopathies. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald’s Heart Disease-A Textbook of Cardiovascular medicine. Philadelphia: Elsevier Saunders, 2005.
Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idio-pathic dilated cardiomyopathy. Am J Cardiol 1998;82:537–540.
Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 2001;87:320–323.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Bulwer, B.E., Solomon, S.D. (2007). Cardiomyopathies. In: Solomon, S.D., Bulwer, B. (eds) Essential Echocardiography. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59259-977-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-977-6_9
Publisher Name: Humana Press
Print ISBN: 978-1-58829-322-0
Online ISBN: 978-1-59259-977-6
eBook Packages: MedicineMedicine (R0)